Chronic Myeloid Leukemia Treatment Discontinuation
0 Views
administrator
06/27/23
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.
-
Category
Show more
Facebook Comments
No comments found